STERIS Announces Outcome of Ethylene Oxide Trial

Core Points - A jury trial against Isomedix Operations, Inc., a subsidiary of STERIS plc, ended in a mistrial on January 17, 2025, after being ongoing since December 4, 2024 [1][2] - The case involves claims of personal injury due to ethylene oxide emissions from a sterilization facility in Waukegan, Illinois, which Isomedix operated from 2005 to 2008 [2] - The court will schedule a re-trial at a later date following the mistrial declaration [2] Company Actions - Isomedix plans to vigorously defend against the allegations related to ethylene oxide operations and emissions from the Waukegan facility [3] - The company has invested in its facilities and implemented processes that meet or exceed applicable environmental regulatory standards [3] Company Overview - STERIS is a leading global provider of products and services focused on infection prevention and patient care [4] - The company emphasizes creating a healthier and safer world through innovative healthcare and life sciences products and services [4]